跳至主要内容
临床试验/CTRI/2021/09/036474
CTRI/2021/09/036474Not Applicable2 期

ââ?¬Å?Clinical study for the evaluation of efficacy and safety of Unani formulation in the management of Cirrhosis of Liverââ?¬?

Deptt of Moalajat School of Unani Medical Education and Research Jamia Hamdard University0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
Not Applicable
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Radiological ( Elastography: Metavir score ââ?°Â¥ f4(i.e. more than 12kPa) evidence of liver cirrhosis
  • Child-turcotte-Pugh Score A and B

排除标准

  • Pregnant women and lactating mothers
  • Mentally retarded patients
  • Patients who failed to give informed consent
  • Patient with Hepatic Encephalopathy
  • Patients with comorbid heart and kidney disease
  • History of active bleeding
  • Severe bacterial infection
  • History of malignancy
  • Patient whose CHILD PUGH score lies in category C
  • Uncontrolled Diabetes Mellitus

研究者

发起方
Deptt of Moalajat School of Unani Medical Education and Research Jamia Hamdard University

相似试验